Designing and conducting a successful HEOR study

A leading global pharmaceutical company was looking for a fit-for-purpose technology and methodology to evaluate the effectiveness of an anti-psychotic drug in terms of relapse, adherence to treatment and patient outcomes.

The complexity of this study came from the fact that it had to be conducted in 19 countries around the world and be adapted to different healthcare systems and languages. This international study proved that using the right technology makes a difference to real-world studies.

...To learn more, downloand the full case study.

More Case Studies

  • Real-world studies in complex treatments

    Cisiv’s EDC platform, Baseline Plus, is built specifically to meet the complex needs of post-approval...

  • Baseline Plus: Ideally suited for orphan drug post-approval studies

    Baseline Plus provided the ideal platform to enable a specialised European Pharma company to run a...

  • Optimising post-approval research: using technology for efficient and cost-effective studies

    A large global Pharma company was required to run a complex global safety study by regulatory authorities. This...

incisive solutions decisive results

©Cisiv 2016 - All Rights Reserved. Registered Company Number : 3110147

Website by 3Men²